Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 27;22(1):418.
doi: 10.1186/s13063-021-05382-7.

Public access to protocols of contemporary cancer randomized clinical trials

Affiliations

Public access to protocols of contemporary cancer randomized clinical trials

Christopher Babu et al. Trials. .

Abstract

Access to randomized clinical trial (RCT) protocols is necessary for the interpretation and reproducibility of the study results, but protocol availability has been lacking. We determined the prevalence of protocol availability for all published cancer RCTs in January 2020. We found that only 36.1% (48/133) of RCTs had an accessible protocol and only 11.3% of RCTs (15/133) had a publicly accessible protocol that was not behind a paywall. Only 18.0% (24/133) of RCTs were published in conjunction with the protocol on the journal website. In conclusion, few cancer RCTs have an accessible research protocol. Journals should require publication of RCT protocols along with manuscripts to improve research transparency.

Keywords: Access; Cancer; Clinical trials; Protocols.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Study Flowchart. RCT, Randomized Clinical Trial

Similar articles

Cited by

References

    1. Chan A, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA. 2004;291:20. doi: 10.1001/jama.291.20.2457. - DOI - PubMed
    1. Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303:20. doi: 10.1001/jama.2010.651. - DOI - PubMed
    1. Lucey M, Clark J, Glasziou P. Public availability of trial protocols. Lancet. 2017;390:10113. doi: 10.1016/S0140-6736(17)33255-5. - DOI - PubMed
    1. Zakeri K, Noticewala S, Vitzthum L, Sojourner E, Shen H, Mell L. 'Optimism bias' in contemporary national clinical trial network phase III trials: Are we improving? Ann Oncol. 2018;29:10. doi: 10.1093/annonc/mdy340. - DOI - PMC - PubMed
    1. Altman DG, Furberg CD, Grimshaw JM, Rothwell PM. Lead editorial: Trials - using the opportunities of electronic publishing to improve the reporting of randomised trials. Trials. 2006;7(1):6. doi: 10.1186/1745-6215-7-6. - DOI - PMC - PubMed